Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...
Hosted on MSN
Pfizer’s new weight-loss shot: Can one injection a month change obesity treatment as we know it?
Pharmaceutical giant Pfizer has unveiled encouraging mid-stage trial results for berobenatide, an experimental anti-obesity and diabetes drug designed to be taken just once a month. If approved, it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results